FLT3 and acute myeloid leukemia: FLT3-ITD mutations have been consistently shown across most studies to be associated with a more aggressive phenotype and worse survival in AML, while most studies have shown no—or only minimal—prognostic impact of FLT3-TKD mutations [19, 20, 27–30].